Axil Capital focuses on biomedical and healthcare technology ventures, investing across early‑stage seed to late‑stage crossover rounds. It seeks to create synergies between Japanese and global life‑science ecosystems by backing innovative therapeutics, platform technologies, medical devices, and digital health solutions that can deliver long‑term value.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
Japan
44.4%France
11.1%United States of America
11.1%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Seed → Series C+
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
TaiAx Life Science Fund L.P.
Vintage 2024 • $200M